Novartis will build a $600 million plant in the United States to develop flu vaccines using advanced, cell-culture techniques. The facility would be based in holly Springs, North Carolina, and...
Read the full post.
A couple of months ago, Ventria Biosciences report having successfully produced recombinant lactoferrin and lysozymes --human proteins shown to help reduce the duration and recurrence of acute...
Read the full post.
Researchers from the University of Virginia Health System and Case Western Reserve University have found out that pioglitazone HCl, a drug designed to treat diabetes may also hold potential in...
Read the full post.
Clothes and textile from corn fibers were again the highlight in the recently concluded World Congress on Industrial Biotechnology and Bioprocessing. A fashion show was held, putting on spotlight...
Read the full post.
Scientists from the Thomas Jefferson University have successfully produced monoclonal antibodies against breast and colorectal cancer in tobacco plants. A gene coding for the an antibody against the...
Read the full post.
The Czech Republic is building a biotech research park in Brno, on the very place where the Father of Genetics, Gregor Mendel, elucidated the laws of genetics and inheritance based on the pea plant....
Read the full post.
The US Food and Drug Administration has approved of the new once-a-day, three-in-one AIDS pill. The drug, called Atripla, was jointly developed by Bristol-Myers Squibb Co and Gilead, Inc, and combines...
Read the full post.
This previous entry on bioentrpreneurship and blogs emphasized the role of web presence for building a (biotech) firm's corporate PR. Apparently, not only firms are increasing their web presence;...
Read the full post.
Scientists have identified a potential new source of multipotent adult stem cells: hair follicles. The mutipotent stem cells grow as masses the investigators call hair spheres. After growing the...
Read the full post.
Better late than never. I almost missed featuring an article in the March issue of Nature's Bioentrepreneur, Why media relations matter (registration required, but free). The article highlights...
Read the full post.
A study to be published in this month's Tissue Engineering report of a novel method of growing immature follicles to fully mature eggs in vitro. The three dimensional culture sytem described,...
Read the full post.
AnorMed has completed enrollment of patients for one of is Phase III clinical trials for with MOZOBIL for stem cell transplant as treatment for Multiple Myeloma, a cancer of the plasma cells. MOZOBIL...
Read the full post.
Just a short Note to commemorate: The Biotech Weblog is a year old! Thanks for all your support!......
Read the full post.
The U.S. Department of Energy (DOE) has released a research "roadmap" for the development of cellulosic ethanol as an alternative fuel source. The scientific document resulting from the...
Read the full post.
Rapamycin (also called sirolimus, marketed as Rapamune® by Wyeth) is a peptide produced by Streptomyces hygroscopicus, originally developed as an antibiotic, but is more commonly used as an...
Read the full post.
Straight from the Doc highlights two plants which could be potential sources of novel drugs: Cranberries as source of lead compounds against dental caries ...scientists have discovered that cranberry...
Read the full post.
What: World Congress on Industrial Biotechnology and Bioprocessing When: July 11-14, 2006 Where: Toronto, Canada Operating on the theme, Linking Biotechnology, Chemistry and Agriculture to Create New...
Read the full post.
The Wellcome Trust, UK's largest charitable foundation supporting biomedical research, is planning to sell sterling bonds to help raise funds to support its scientific and medical research....
Read the full post.
The Center for Medical Genome Research in Berlin was officially opened last week. A joint project between the Max Delbrueck Center for Molecular Medicine (MDC) Berlin-Buch and the Leibniz-Institut...
Read the full post.
